Synthesis and Cytotoxic Activity of (4-Substituted-benzylidene)-(3-Phenyl-1,2,4-Oxadiazol-5-YL)Methylamines
- 作者: Kucukoglu K.1, Tugrak M.1, Demirtas A.1, Sakagami H.2, Gul H.I.1
-
隶属关系:
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ataturk University
- Division of Pharmacology, School of Dentistry, Meikai University
- 期: 卷 50, 编号 4 (2016)
- 页面: 234-238
- 栏目: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244350
- DOI: https://doi.org/10.1007/s11094-016-1429-7
- ID: 244350
如何引用文章
详细
This work was aimed at the synthesis and investigation of the cytotoxic activity of a series of Schiff bases having (4-substituted-benzylidene)-(3-phenyl-1,2,4-oxadiazol-5-yl)methylamine structure with different electronic natures of substituents in the phenyl ring. Thus, the study was intended to observe the effect of substituents with different electronic properties on the cytotoxic activity. The synthesized series of compounds (OP) were obtained by six-step synthesis with yields ranging from 12.23 to 25.77%. The chemical structures of these compounds were elucidated by H NMR. The cytotoxicity of compounds against human oral squamous cell carcinoma cell lines [Ca9-22 (gum), HSC-2 (mouth), HSC-3 (fluent), HSC-4 (language)] and human oral normal cells [HGF (gum fibroblasts), HPC (pulp cells), and HPLF (periodontal ligament fibroblasts)] was tested by MTT assay. Among the group of six OP compounds, bromo derivative OP2, non-substituted derivative OP1, and chloro derivative OP3 showed higher cytotoxicity (2.71-, 1.56-, and 1.53-fold, respectively) than the reference compound 5-FU. In addition, OP2 (3.27) exhibited the greatest selectivity index in this group. These compounds can be considered to be model structures for further studies.
作者简介
K. Kucukoglu
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ataturk University
编辑信件的主要联系方式.
Email: kucukogluk35@hotmail.com
土耳其, Erzurum
M. Tugrak
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ataturk University
Email: sakagami@dent.meikai.ac.jp
土耳其, Erzurum
A. Demirtas
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ataturk University
Email: sakagami@dent.meikai.ac.jp
土耳其, Erzurum
H. Sakagami
Division of Pharmacology, School of Dentistry, Meikai University
编辑信件的主要联系方式.
Email: sakagami@dent.meikai.ac.jp
日本, Sakado, Saitama, 350-0283
H. Gul
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ataturk University
Email: sakagami@dent.meikai.ac.jp
土耳其, Erzurum
补充文件
